Cardinal Health stock falls 1.64 percent as estimates point to growth

Published on 09/23/2026 at 15:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cardinal Health stock closed at USD 222.04 on September 22, 2026, down 1.64 percent. Zacks expects USD 2.92 EPS and USD 66.96 billion revenue.

Fotorealistisches Pharma-Distributionslager mit Gabelstapler und Mitarbeitern in Dublin Ohio — Cardinal Health Inc. betreibt ein modernes Pharma-Distributionslager in Dublin, Ohio – ISIN US14149Y1082, Illustration mit AI erstellt.

Cardinal Health (ISIN US14149Y1082) closed at USD 222.04 on the NYSE on September 22, 2026, down 1.64 percent from the prior session. The next quarterly estimate calls for USD 2.92 in earnings per share and USD 66.96 billion in revenue.

Estimates point to higher earnings

According to Zacks on September 22, 2026, the upcoming quarter is expected to produce USD 2.92 EPS, 14.51 percent above the prior-year quarter, while revenue is projected at USD 66.96 billion, 4.6 percent higher year over year.

The same September 22, 2026 estimate set projects full-year earnings of USD 12.55 per share and revenue of USD 266.02 billion, representing increases of 11.46 percent and 4.63 percent from the prior year, respectively. These are forecasts rather than reported results, so the earnings release remains the next numerical test for the stock.

Stock remains below its yearly high

Market data for September 22, 2026 show a 52-week range of USD 145.87 to USD 258.30, with the closing price USD 36.26 below the high and USD 76.17 above the low. The session volume was 2.71 million shares, compared with an average volume of 1.53 million shares.

Cardinal Health's market capitalization was USD 51.53 billion as of September 22, 2026. The price decline therefore came with trading volume about 77 percent above the stated average, giving the move more weight than a session with below-average turnover.

Valuation keeps the focus on delivery

A September 23, 2026 analysis from Simply Wall St put the share price at USD 222.04 and examined whether current earnings support the valuation. A separate September 22, 2026 sector analysis reported a forward price-to-earnings ratio of 17.55 times and said the fiscal 2027 consensus implies 11.5 percent earnings growth.

For investors, the central comparison is now between the forecast 14.51 percent quarterly EPS increase and the 1.64 percent share-price decline recorded on September 22, 2026. The market is pricing the next earnings update against both the projected USD 66.96 billion revenue base and the stock's position below its USD 258.30 52-week high.

Cardinal Health stock closes at USD 222.04

Cardinal Health stock closed at USD 222.04 on the NYSE on September 22, 2026, down 1.64 percent from the previous session. The closing price, 52-week range, volume and market capitalization are dated to that completed trading session.